Furthermore, the unique PDE5 expression patterns observed in breast cancer tissues and the mounting evidence of the anticancer properties of cGMP signaling warrant further investigation into this signaling pathway as a potential target for future anticancer drug discovery efforts. Here, PDE5A is linked to breast cancer.